P. Høegh-Andersen

In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?

M. Karsdal, L. Tankó, P. Qvist, 2005, Assay and drug development technologies.

Measurement of tumor load and distribution in a model of cancer-induced osteolysis: A necessary precaution when testing novel anti-resorptive therapies

J. Delaissé, N. Brünner, B. Winding, 2004, Clinical & Experimental Metastasis.

Estradiol Enhances Osteolytic Lesions in Mice Inoculated with Human Estrogen Receptor-Negative MDA-231 Breast Cancer Cells in vivo

N. Brünner, B. Winding, P. Høegh-Andersen, 2003, Breast Cancer Research and Treatment.

Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo.

M. Karsdal, J. Bollerslev, T. Ueland, 2005, The American journal of pathology.

Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation.

Claus Christiansen, Kim Henriksen, M. Karsdal, 2006, Arthritis and rheumatism.

Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application

L. Tankó, J. Delaissé, T. L. Andersen, 2004, Arthritis research & therapy.

Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM)

C. Christiansen, L. Tankó, J. Delaissé, 2004, Menopause.

Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.

Nils Brünner, Claus Holst-Hansen, N. Brünner, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.